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Choledochal malformations (CMs) are defined as dilatations of the 
biliary tree in various distributions and configurations. The majority 
are found in the extrahepatic ducts, but certain types (IVa and V) 
involve the intrahepatic biliary tree. The incidence of CM varies 
around the world, with the incidence in the United States of America 
reported as 1:150 000, the Netherlands 1:59 000 and in Asia as 
1:10 000.[1] Currently, there are no reliable data reflecting the 
incidence of CM in South Africa.
Three patterns of presentation have been identified in childhood. 
During the antenatal period lesions may be identified during routine 
ultrasound screening as a cystic mass in the porta hepatis. After birth, 
cysts may present during two broad time frames, either in infancy 
when they typically present with jaundice and a palpable right upper 
quadrant mass, or later in childhood with features of obstructive 
jaundice, cholangitis or pancreatitis.  
Alonso-Lej et al.[2] initially described two types of CM. Todani 
et al.[3] later expanded the classification to include intrahepatic and 
multiple cysts. They described 5 different subtypes depending on 
the location (extrahepatic, intrahepatic, or a combination of the 
two) and shape (cystic or fusiform) of the malformation: type I is a 
cystic or fusiform dilatation of the extrahepatic biliary system; type 
II is a diverticulum coming off the common bile duct; type III is a 
choledochocele involving dilatation at the distal tip of the bile duct; 
type IV is a dilatation of the extra- and intrahepatic ductal system; 
and type V involves intrahepatic duct dilatation with or without liver 
fibrosis.
The typically described trio of pain, a right upper quadrant mass 
lesion and jaundice is rarely seen in our population. The spectrum 
of presentation of CM is varied, ranging from an asymptomatic 
child who is incidentally diagnosed to patients presenting with 
obstructive symptoms including stone formation, cholangitis and 
pancreatitis. Although these early complications are often the reason 
for presentation and subsequent management, asymptomatic cysts 
are also resected to negate the risk of developing cholangiocarcinoma 
in later years.[4] 
Methods
We performed a retrospective record review of all patients with the 
diagnosis of a CM treated at the Department of Paediatric Surgery, 
Faculty of Health Sciences, University of the Witwatersrand between 
January 2010 and May 2017. Ethics approval was granted by the 
University of the Witwatersrand Human Research Ethics Committee 
(ref. no. M170646).
Results
Over the 7.5-year study period, 35 patients were identified but only 
33 were included in the study owing to incomplete clinical records 
for 2 of the patients. All of the patients had undergone resection 
of the cyst with reconstruction using a Roux-on-Y hepatico- 
jujenostomy. The median (interquartile range (IQR)) age at surgery 
was 31 (4 - 60) months. Most of our patients (83%; n=27) presented 
with jaundice and a median (IQR) bilirubin concentration of 
167 (32 - 234) mmol/L and a raised median (IQR) gamma glutamyl 
transferase concentration of 706 (282 - 1 233) IU/L. A total of 26 
patients had their lesions classified according to Todani et al.[3] – there 
were 19 type I lesions and 7 type IVa lesions. Patients with type IV 
lesions presented at a younger age (Fig. 1) and with higher bilirubin 
levels (Fig. 2), although this finding was not statistically significant. 
Discussion
Types I and IV CM are most likely to present with obstructive 
symptoms[5] as seen in 83% of our patients. These lesions are also 
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Background. Choledochal malformation (CM) is a well-described and relatively rare condition. CMs may present on antenatal ultrasound 
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malunion predisposes to the development of CMs. 
Objectives. To review the experience of CMs in the Department of Paediatric Surgery, University of the Witwatersrand, Johannesburg to 
improve our patient care for this population.
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this finding was not statistically significant.
Conclusion. Although uncommon, CMs may lead to significant morbidity and malignancy. Specialised care is necessary to improve long-
term outcomes in these patients.
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more commonly associated with the anomalous pancreaticobiliary 
malunion described by Babbit in 1969.[6] As the length of the common 
channel increases, the ampulla of Vater is found progressively more 
distally in the duodenum.[7] This anomalous anatomy results in 
increased reflux of pancreatic and biliary secretions into the proximal 
common bile duct, causing inflammation and stone formation. 
These preceding insults result directly in obstructive jaundice, 
pancreatitis and an increased risk of malignancy in the biliary tree. 
The pathogenesis of cholangiocarcinoma in this setting remains 
debatable. It is postulated that the combination of refluxed pancreatic 
juice and biliary stasis is pathological and causes acute inflammation, 
which progresses to chronic inflammation that renders the biliary 
epithelium susceptible to the development of cholangiocar- 
cinoma.[8] Presentation with cholangiocarcinoma in CM during 
childhood is reported in 0.42% of cases compared with 11.4% 
in adults. It is prudent to note that once surgical resection and 
reconstruction for CM has taken place, there is still a 14% risk of 
developing malignant disease later in life.[9]
Other congenital anomalies are not frequently associated with CM. 
However, Murphy et al.[10] described associated cardiac anomalies in 
44.9% of CM who presented under the age of 1 year. This association 
decreased to 6.9% in the older age group. Routine cardiac screening 
using an echocardiogram should be considered in patients younger 
than 12 months of age with a CM.
The clinical differentiation between type I and type IVa cysts 
is difficult. Careful consideration must be given to whether the 
intrahepatic ductal dilatation is secondary to biliary obstruction 
from the extrahepatic component, thus making it a type I or whether 
there is pathological separate intrahepatic dilation, with or without 
stricturing in the proximal hepatic ductal system as in type IVa.[11] 
This diagnostic doubt can result in classification issues, as well as 
leading to discrepant surgical management of these cases. In type 
IVa cases with an identifiable stricture, percutaneous transhepatic 
cholangiography with biliary balloon dilatation may be considered, 
as may open stricturoplasty. If there is localised intrahepatic 
duct dilatation surgeons may consider localised liver resection in 
conjunction with resection of the extrahepatic component of the CM. 
In cases where no stricture is noted and focal intrahepatic biliary 
dilatation occurs that is thought to be pathological, resection of the 
extrahepatic component of the CM resection is undertaken with close 
follow-up to determine resolution of the dilated intrahepatic segments.
Diao et al. [12] demonstrated no stage IV fibrosis on neonates 
operated on under 1 mont of age, but a 25% incidence of stage IV 
fibrosis in their cohort of infants operated on after 1 month of age 
(p=0.03). Their group demonstrated no difference in perioperative 
morbidity between the two groups, confirming the feasibility and 
safety of surgery in this younger population. With the increase in the 
availability of antenatal ultrasound screening and earlier detection of 
CM, neonatal surgery should be strongly considered.
In our experience, the diagnosis can be made with an 
ultrasound in most cases when taking into account the clinical and 
laboratory associations. We have not found magnetic resonance 
cholangiopancreatography (MRCP) to be beneficial in neonates and 
infants owing to the difficulty in tissue differentiation and poorly 
reconstructed 3D images; however, in the older group of children, 
MRCP aids the diagnosis of anomalies of biliary anatomy and also 
the planning of the intra-operative biliary reconstruction. In patients 
where pre-operative MRCP is not suitable, an on-table cholangiogram 
provides the ductal road map demonstrating aberrant hepatic ductal 
variations that require alternative reconstruction planning.
Management involves removing the involved segment of the 
biliary tree but cognisance must be given to the small nuances 
that may lead to morbidity if neglected.[13] Removal of the entire 
involved common bile duct often necessitates entering the head of 
the pancreas with care not to damage the pancreatic duct. Although 
some units advocate insertion of a choledochal scope to visualise and 
remove any stones in both the distal and proximal ducts, we generally 
find that irrigation of the proximal ductal structures is sufficient. 
In the majority of type I and IVa CMs, the distal duct is completely 
obliterated and there is no need to suture-ligate the distal duct unless 
patency is observed.
In Johannesburg, the incidence of bile stones is rare and the majority 
of patients present with large amounts of sludge in the choledochal 
cyst. This sludge still results in obstructive symptomatology and 
should thus be washed out. Shorter Roux-on-Y limbs may be utilised 
in patients with CM as compared with those with biliary atresia. 
The enteric anastomosis is performed as an end-side, or end-end 
anastomosis taking care not to cause narrowing of the anastomosis. 
End-to-side anastomoses should be close to the limb end to avoid a 
blind-ending limb and subsequent stasis.
There have been remarkable advancements in the field of paediatric 
laparoscopic surgery. Multiple centres have embarked on endoscopic 
CM surgery and continue to do so; the advantages include decreased 
length of hospital stay and improved cosmesis. However, the literature 
has shown a large increase in the short-term complications and 
concern over the long-term increased risk of malignancy secondary 
to incomplete excision.
In 2017, Stringer[13] reported on the evidence for lower biliary 
anastomosis in endoscopic reconstructions resulting in increased 
stricture rates requiring redo surgery, difficult visualisation of the 
distal duct remnant resulting in a large distal duct remnant being left 
in situ, and increased incidence of vascular injuries in endoscopic 
procedures. Most endoscopic surgeons propose the use of hepatico-
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Fig. 1. Choledochal malformation type v. age at presentation.
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Fig. 2. Choledchal malformation type v. bilirubin level at presentation.
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duodenostomy over the conventional Roux-on-Y reconstruction 
owing to its ease in performing endoscopically. However, this 
predisposes patients to bile reflux and gastritis, with a potential 
increased risk of gastric malignancies. Stringer[17] also remarks that 
laparoscopic CM resections are often delayed until after 1 year of 
age to facilitate a technically easier procedure; however, increased 
liver damage is established during this waiting period. It seems that 
robotic surgery is not exempt from these problems, with an incidence 
of 14% early complication rates.[14]
Conclusion
CMs have a low incidence in the general population but are 
commonly seen in paediatric surgical practice. Early surgery protects 
the liver from advanced fibrosis and can be performed safely with the 
correct support services.
Long-term follow-up is mandatory as the risk of malignancy is not 
completely mitigated by resection of the CM.
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